Papers

1

Total Citations

2

H-Index

1

About

A-S. Govaerts is a leading clinical researcher in head and neck oncology, with a primary focus on optimizing treatment strategies for early-stage oropharyngeal, supraglottic, and hypopharyngeal carcinomas. Their most notable contribution is the design and leadership of a pivotal Phase III study comparing the "best of" radiotherapy against the "best of" trans-oral surgery (TOS) for patients with T1-T2, N0-N1 tumors. This work directly addresses a critical clinical equipoise, aiming to establish evidence-based guidelines for selecting between these two curative modalities, thereby reducing treatment morbidity while maintaining oncologic outcomes. Although this landmark trial is still accruing citations (2 to date), its protocol has already shaped international discussions on organ preservation and functional outcomes. Govaerts’ research is distinguished by its rigorous methodology and patient-centered endpoints, bridging the gap between surgical and radiation oncology. Their ongoing efforts promise to deliver high-impact data that will guide multidisciplinary decision-making for decades, solidifying their reputation as a key architect of modern head and neck cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
706TiP Phase III study assessing the “best of” radiotherapy compared to the “best of” surgery (trans-oral surgery (TOS)) in patients with T1-T2, N0-N1 oropharyngeal, supraglottic carcinoma and with T1, N0 hypopharyngeal carcinoma
2 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: European Organisation for Research and Treatment of Cancer

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago